Clinical Research Directory
Browse clinical research sites, groups, and studies.
PRecision Oncology CUhk pRogrammE (PRO-CURE)
Sponsor: Brigette Ma
Summary
The main aim of this project is to establish an innovative model of a comprehensive precision oncology platform to help individualizing drug therapy for patients with advanced cancers at The Chinese University of Hong Kong. The other objectives include to optimize the genomic matching and access of patients with unique cancer subtypes to the relevant clinical trials of novel therapies, and to construct a personalized drug screening platform for individuals using novel cancer models established from patient-derived cancer cells and tissues. Other objectives include to investigate the utility and feasibility of genomic sequencing using circulating tumor DNA(ctDNA), and to establish a biobank of tumor tissues derived from patients with unique cancer subtypes.
Official title: Comprehensive Precision Oncology Program at The Chinese University of Hong Kong
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2019-10-16
Completion Date
2026-12-31
Last Updated
2024-08-22
Healthy Volunteers
No
Conditions
Interventions
NGS, PDO/PDX establishment
Patients' tumor specimens will be collected for next generation sequencing, PDO/PDX establishment and tissue banking.
Locations (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong